Liquid Biopsy Market Report, Size, Share, Analysis 2017 and Forecast to 2023.

According to Stratistics MRC, the Global Liquid Biopsy market is expected to grow from $310.0 million in 2016 to reach $1201.52 million by 2023 with a CAGR of 21.3%.

Gaithersburg, Maryland, United States - January 9, 2018 /MarketersMedia/ —

Increasing research & developments and clinical trials for diagnostics, and technological developments are some of the factors driving the market growth. Moreover, growing prevalence of cancer, increasing awareness about liquid biopsy are the factors fostering the market growth. On the other hand, higher costs and complex regulations are restraining the market growth.

Request for sample here:
http://www.strategymrc.com/report/liquid-biopsy-market-2017/request-sample

Liquid biopsy tests are used to help find cancer at an early stage. These tests are performed to interpret the molecular aspects of cancer across the healthcare and research settings, such as research laboratories, physicians, pathological and hospitals. The circulating tumor cells leads the market globally with the largest market share and is expected to grow with a highest CAGR during the forecast period. By cancer type, lung cancer segment is expected to witness high growth rate during the forecast period. North America emerged as the major revenue generating region in the global market due to innovative technological developments, and increasing incidence of cancer rates in the Canada and U.S.

Access the complete report at: http://www.strategymrc.com/report/liquid-biopsy-market-2017

Some of the key players in global liquid biopsy market include Roche Diagnostics, Guardant Health, Inc, Illumina, Inc, Biocept, Inc, Myriad Genetics, Inc, Qiagen N.V. , Genomic Health, Inc, Thermo Fisher Scientific Inc , Bio-Rad Laboratories, Inc, Epic Sciences, Exosome, Cynvenio, Guardant Health, Personal Genome Diagnostics and Janssen Diagnostics, LLC.

Make an inquiry at:
http://www.strategymrc.com/report/liquid-biopsy-market-2017

Clinical Applications Covered:
• Treatment Monitoring
• Recurrence Monitoring
• Early Cancer Screening
• Therapy Selection

Product and Services Covered:
• Platforms & Instruments
• Assay Kits & Reagents
• Services

Cancer Types Covered:
• Breast Cancer
• Liver Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Other Cancer Types

Circulating Biomarkers Covered:
• Circulating Tumor DNA (CTDNA)
• Extracellular Vesicles (Evs)
• Circulating Tumor Cells
• Cell-Free DNA
• Exosomes
• Other Circulating Biomarkers

Sample Types Covered:
• Urine
• Blood
• Other Sample Types

End Users Covered:
• Academic and Research Centers
• Hospitals and Physician Laboratories
• Diagnostic centres & Reference Laboratories

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Follow us on Twitter: https://twitter.com/StratisticsMRC

Follow us on LinkedIn at: https://www.linkedin.com/company/stratistics-market-research-consulting-pvt-ltd?trk=mini-profile

About Stratistics MRC
We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends.

Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.

Contact Info:
Name: James Lamb
Email: Send Email
Organization: Stratistics Market Research Consulting Pvt Ltd

Source URL: https://marketersmedia.com/liquid-biopsy-market-report-size-share-analysis-2017-and-forecast-to-2023/285051

For more information, please visit http://www.strategymrc.com

Source: MarketersMedia

Release ID: 285051